IL1B and diabetic kidney disease: The expression of miR-93-5p was shown to be decreased in diabetic nephropathy, again under the regulation of lncRNA, and its inhibition reduced fibrosis and inflammation with a reduction in TNF-α, IL-6, and IL-1β [42].